共 25 条
- [1] Lobar or Sublobar Resection for Peripheral Stage IA Non-Small-Cell Lung Cancer[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (06) : 489 - 498Altorki, NasserWang, XiaofeiKozono, DavidWatt, ColleenLandrenau, RodneyWigle, DennisPort, JeffreyJones, David R.Conti, MassimoAshrafi, Ahmad S.Liberman, MoisheYasufuku, KazuhiroYang, StephenMitchell, John D.Pass, HarveyKeenan, RobertBauer, ThomasMiller, DanielKohman, Leslie J.Stinchcombe, Thomas E.Vokes, Everett
- [2] Current Panorama and Challenges for Neoadjuvant Cancer Immunotherapy[J]. CLINICAL CANCER RESEARCH, 2020, 26 (19) : 5068 - 5077Benitez, Jose CarlosRemon, JordiBesse, Benjamin
- [3] Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial[J]. NATURE MEDICINE, 2023, 29 (3) : 593 - 604Cascone, TinaLeung, Cheuk H.Weissferdt, AnnikkaPataer, AparCarter, Brett W.Godoy, Myrna C. B.Feldman, HopeWilliam Jr, William N.Xi, YuanxinBasu, SreyashiSun, Jing JingYadav, Shalini S.Rojas Alvarez, Frank R.Lee, YoungheeMishra, Aditya K.Chen, LiliPradhan, MonikaGuo, HaipingSinjab, AnsamZhou, NicolasNegrao, Marcelo V.Le, XiuningGay, Carl M.Tsao, Anne S.Byers, Lauren AverettAltan, MehmetGlisson, Bonnie S.Fossella, Frank V.Elamin, Yasir Y.Blumenschein, GeorgeZhang, JianjunSkoulidis, FerdinandosWu, JiaMehran, Reza J.Rice, David C.Walsh, Garrett L.Hofstetter, Wayne L.Rajaram, RaviAntonoff, Mara B.Fujimoto, JunyaSolis, Luisa M.Parra, Edwin R.Haymaker, CaraWistuba, Ignacio I.Swisher, Stephen G.Vaporciyan, Ara A.Lin, Heather Y.Wang, JingGibbons, Don L.Jack Lee, J.
- [4] Integrating genomic features for non-invasive early lung cancer detection[J]. NATURE, 2020, 580 (7802) : 245 - +Chabon, Jacob J.Hamilton, Emily G.Kurtz, David M.Esfahani, Mohammad S.Moding, Everett J.Stehr, HenningSchroers-Martin, JosephNabet, Barzin Y.Chen, BinbinChaudhuri, Aadel A.Liu, Chih LongHui, Angela B.Jin, Michael C.Azad, Tej D.Almanza, DiegoJeon, Young-JunNesselbush, Monica C.Keh, Lyron Co TingBonilla, Rene F.Yoo, Christopher H.Ko, Ryan B.Chen, Emily L.Merriott, David J.Massion, Pierre P.Mansfield, Aaron S.Jen, JinRen, Hong Z.Lin, Steven H.Costantino, Christina L.Burr, RisaTibshirani, RobertGambhir, Sanjiv S.Berry, Gerald J.Jensen, Kristin C.West, Robert B.Neal, Joel W.Wakelee, Heather A.Loo, Billy W., Jr.Kunder, Christian A.Leung, Ann N.Lui, Natalie S.Berry, Mark F.Shrager, Joseph B.Nair, Viswam S.Haber, Daniel A.Sequist, Lecia V.Alizadeh, Ash A.Diehn, Maximilian
- [5] Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB-IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial[J]. LANCET, 2021, 398 (10308) : 1344 - 1357Felip, EnriquetaAltorki, NasserZhou, CaicunCsoszi, TiborVynnychenko, IhorGoloborodko, OleksandrLuft, AlexanderAkopov, AndreyMartinez-Marti, AlexKenmotsu, HirotsuguChen, Yuh-MinChella, AntonioSugawara, ShunichiVoong, DavidWu, FanYi, JingDeng, YuMcCleland, MarkBennett, ElizabethGitlitz, BarbaraWakelee, Heather
- [6] Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (21) : 1973 - 1985Forde, Patrick M.Spicer, JonathanLu, ShunProvencio, MarianoMitsudomi, TetsuyaAwad, Mark M.Felip, EnriquetaBroderick, Stephen R.Brahmer, Julie R.Swanson, Scott J.Kerr, KeithWang, ChangliCiuleanu, Tudor-EliadeSaylors, Gene B.Tanaka, FumihiroIto, HiroyukiChen, Ke-NengLiberman, MoisheVokes, Everett E.Taube, Janis M.Dorange, CecileCai, JunliangFiore, JosephJarkowski, AnthonyBalli, DavidSausen, MarkPandya, DimpleCalvet, Christophe Y.Girard, Nicolas
- [7] Heymach JV., 2023, AACR
- [8] Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer[J]. NATURE MEDICINE, 2022, 28 (11) : 2353 - +Jee, JustinLebow, Emily S.Yeh, RandyDas, Jeeban P.Namakydoust, AzadehPaik, Paul K.Chaft, Jamie E.Jayakumaran, GowthamBrannon, A. RoseBenayed, RymaZehir, AhmetDonoghue, MarkSchultz, NikolausChakravarty, DebyaniKundra, RitikaMadupuri, RamyasreeMurciano-Goroff, Yonina R.Tu, Hai-YanXu, Chong-RuiMartinez, AndresWilhelm, ClareGalle, JesseDaly, BobbyYu, Helena A.Offin, MichaelHellmann, Matthew D.Lito, PiroArbour, Kathryn C.Zauderer, Marjorie G.Kris, Mark G.Ng, Kenneth K.Eng, JulianaPreeshagul, IsabelLai, W. VictoriaFiore, John J.Iqbal, AfsheenMolena, DanielaRocco, GaetanoPark, Bernard J.Lim, Lee P.Li, MarkTong-Li, CandaceDe Silva, MadhawaChan, David L.Diakos, Connie, IItchins, MalindaClarke, StephenPavlakis, NickLee, AdrianRekhtman, Natasha
- [9] Neoadjuvant Immunotherapy for High-Risk, Resectable Malignancies: Scientific Rationale and Clinical Challenges[J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2021, 113 (07): : 823 - 832Krishnamoorthy, MithunahLenehan, John G.Vareki, Saman Maleki
- [10] Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (04) : 351 - 360Le Chevalier, TArriagada, RLe Péchoux, CGrunenwald, DDunant, APignon, JPTarayre, MAbratt, RArriagada, RBergman, BGralla, RGrunenwald, DLe Chevalier, TOrlowski, TPapadakis, EPinel, MISAraujo, CDella Torre, Hde Solchaga, MMAbdi, EBlum, RBall, DBasser, RDe Boer, RBishop, JBrigham, BDavis, SFox, DRichardson, GWyld, DPirker, RHumblet, YDelaunois, LVan Meerbeeck, JPGermonpre, PVansteenkiste, JNackaerts, KPinel, MISVauthier, GYounes, RNArriagada, RBaeza, RCarvajal, PKleinman, SOrlandi, LCastro, CGodoy, JKosatova, KGaafar, RAzarian, R